Filing Details
- Accession Number:
- 0001209191-20-004156
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2020-01-17 18:33:03
- Reporting Period:
- 2019-12-31
- Accepted Time:
- 2020-01-17 18:33:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1673772 | Rapt Therapeutics Inc. | RAPT | Pharmaceutical Preparations (2834) | 473313701 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1791244 | Wendye Robbins | C/O Rapt Therapeutics, Inc. 561 Eccles Avenue South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-10-31 | 50 | $12.75 | 1,650 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-11-27 | 78 | $26.60 | 1,728 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-12-02 | 200 | $21.87 | 1,928 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-12-03 | 22 | $23.07 | 1,950 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |